BARD1 and cancer: Rofes et al. used the gnomAD non-Finnish European population, non-cancer dataset as a control population for their study. This study showed results that support the role of BARD1 as a moderate-penetrance BC-predisposing gene and highlight a strong association with triple-negative tumors.